Skip to main content

Advertisement

Log in

Cogan’s Syndrome: Clinical Presentations and Update on Treatment

  • Autoimmunity (T Tarrant, Section Editor)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Cogan’s syndrome (CS) is a rare systemic vasculitis that can severely affect vision and hearing, which may also have significant systemic effects. Early recognition of this autoimmune disorder and intervention can minimize disabling and irreversible damage.

Recent Findings

This article will review the varying clinical presentations of CS and emerging information of systemic disease associated with CS. We will also review recently published promising treatment outcomes using immune modulating medications.

Summary

As our framework for recognizing the markers of CS and the associated systemic disorders expands, more effective guidelines and treatment options may emerge.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine. 1980;59:426–41.

    Article  CAS  Google Scholar 

  2. Vollertsen RS, McDonald TJ, Younge BR, et al. Cogan’s syndrome: 18 cases and a review of the literature. Mayo Clin Proc. 1986;61:344–61. https://doi.org/10.1016/s0025-6196(12)61951-x.

    Article  CAS  PubMed  Google Scholar 

  3. Gluth MB, Baratz KH, Matteson EL, Driscoll CL. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc. 2006;81:483–8. https://doi.org/10.4065/81.4.483.

    Article  PubMed  Google Scholar 

  4. Mora P, Calzetti G, Ghirardini S, et al. Cogan’s syndrome: state of the art of systemic immunosuppressive treatment in adult and pediatric patients. Autoimmun Rev. 2017;16:385–90. https://doi.org/10.1016/j.autrev.2017.02.009Systematic review of combination therapy for Cogan’s syndrome.

    Article  CAS  PubMed  Google Scholar 

  5. Durtette C, Hachulla E, Resche-Rigon M, et al. Cogan syndrome: characteristics, outcome and treatment in a French nationwide retrospective study and literature review. Autoimmun Rev. 2017;16:1219–23. https://doi.org/10.1016/j.autrev.2017.10.005Most recent large (62 patients) retrospective review of Cogan’s syndrome with comparison data regarding therapeutic agents.

    Article  PubMed  Google Scholar 

  6. Morgan RF, Baumgartner CJ. Meniere’s disease complicated by recurrent interstitial keratitis: excellent result following cervical ganglionectomy. West J Surg. 1934;42:628.

    Google Scholar 

  7. Cogan DG. Syndrome of non-syphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol. 1945;33:144–9.

    Article  Google Scholar 

  8. Greco A, Gallo A, Fusconi M, Magliulo G, Turchetta R, Marinelli C, et al. Cogan’s syndrome: an autoimmune inner ear disease. Autoimmun Rev. 2013;12:396–400. https://doi.org/10.1016/j.autrev.2012.07.012.

    Article  CAS  PubMed  Google Scholar 

  9. Kessel A, Vadasz Z, Toubi E. Cogan syndrome – pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2014;13:351–4. https://doi.org/10.1016/j.autrev.2014.01.002.

    Article  PubMed  Google Scholar 

  10. Lunardi C, Bason C, Leandri M, Navone R, Lestani M, Millo E, et al. Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. Lancet. 2002;360:915–21. https://doi.org/10.1016/S0140-6736(02)11028-2.

    Article  CAS  PubMed  Google Scholar 

  11. Jung DH, Nadol JB Jr, Folkerth RD, Merola JF. Histopathology of the inner ear in a case with recent onset of Cogan’s syndrome: evidence for vasculitis. Ann Otol Rhinol Laryngol. 2016;125:20–4. https://doi.org/10.1177/0003489415595426.

    Article  PubMed  Google Scholar 

  12. Grasland A, Pouchot J, Hachulla E, Blétry O, Papo T, Vinceneux P, et al. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology. 2004;43:1007–15. https://doi.org/10.1093/rheumatology/keh228.

    Article  CAS  PubMed  Google Scholar 

  13. Espinoza GM, Prost A. Cogan’s syndrome and other ocular vasculitides. Curr Rheumatol Rep. 2015;17:24. https://doi.org/10.1007/s11926-015-0499-y.

    Article  PubMed  Google Scholar 

  14. Shahid FL, Mukherjee R, Knapp C. Cogan’s syndrome associated with orbital inflammation. Orbit. 2013;32:206–7. https://doi.org/10.3109/01676830.2013.764324.

    Article  PubMed  Google Scholar 

  15. Singer JR, Reddy RK. Serous neurosensory retinal detachment associated with atypical Cogan syndrome: a case report. Retin Cases Brief Rep. 2015;9:315–9. https://doi.org/10.1097/ICB.0000000000000201.

    Article  PubMed  Google Scholar 

  16. Colodetti R, Spina G, Leal T, et al. Cogan’s syndrome – a rare aortitis, difficult to diagnose but with therapeutic potential. Rev Assoc Med Bras (1992). 2017;63:1028–31. https://doi.org/10.1590/1806-9282.63.12.1028Important description of the most common systemic vascular complication of Cogan’s syndrome.

    Article  Google Scholar 

  17. Shamriz O, Tal Y, Gross M. Autoimmune inner ear disease: immune biomarkers, audiovestibular aspects, and therapeutic modalities of Cogan’s syndrome. J Immunol Res. 2018;2018:1498640–8. https://doi.org/10.1155/2018/1498640.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Vavricka SR, Greuter T, Scharl M, Mantzaris G, Shitrit AB, Filip R, et al. Cogan’s syndrome in patients with inflammatory bowel disease – a case series. J Crohns Colitis. 2015;9:886–90. https://doi.org/10.1093/ecco-jcc/jjv128.

    Article  PubMed  Google Scholar 

  19. Scharl M, Frei P, Fried M, Rogler G, Vavricka SR. Association between Cogan’s syndrome and inflammatory bowel disease: a case series. J Crohns Colitis. 2011;5:64–8. https://doi.org/10.1016/j.crohns.2010.09.003.

    Article  PubMed  Google Scholar 

  20. Branislava I, Marijana T, Nemanja D, Dragan S, Maja Z. Atypical Cogan’s syndrome associated with coronary disease. Chin Med J. 2011;124:3192–4.

    PubMed  Google Scholar 

  21. Gaubitz M, Lubben B, Seidel M, et al. Cogan’s syndrome: organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature. Clin Exp Rheumatol. 2001;19:463–9.

    CAS  PubMed  Google Scholar 

  22. Gasparovic H, Djuric Z, Bosnic D, Petricevic M, Brida M, Dotlic S, et al. Aortic root vasculitis associated with Cogan’s syndrome. Ann Thorac Surg. 2011;92:340–1. https://doi.org/10.1016/j.athoracsur.2010.12.068.

    Article  PubMed  Google Scholar 

  23. Hautefort C, Loundon N, Montchilova M, Marlin S, Garabedian EN, Ulinski T. Mycophenolate mofetil as a treatment of steroid dependent Cogan’s syndrome in childhood. Int J Pediatr Otorhinolaryngol. 2009;73:1477–9. https://doi.org/10.1016/j.ijporl.2009.06.025.

    Article  PubMed  Google Scholar 

  24. Pagnini I, Zannin ME, Vittadello F, Sari M, Simonini G, Cimaz R, et al. Clinical features and outcome of Cogan syndrome. J Pediatr. 2012;160:303–7. https://doi.org/10.1016/jpeds.2011.07.051.

    Article  PubMed  Google Scholar 

  25. Sakano H, Harris JP. Emerging options in immune-mediated hearing loss. Laryngoscope Investig Otolaryngol. 2018;4:102–8. https://doi.org/10.1002/lio2.205Nicely delineated treatment options for autoimmune inflammation of the inner ear that is a hallmark of Cogan’s syndrome.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Padoan R, Cazzador D, Pendolino AL, et al. Cogan’s syndrome: new therapeutic approaches in the biological era. Expert Opin Biol Ther. 2019;19:781–8. https://doi.org/10.1080/14712598.2019.1611779Comprehensive review of rising role of biologic agents in the treatment of Cogan’s syndrome.

    Article  CAS  PubMed  Google Scholar 

  27. Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, Mcdonald TJ, et al. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum. 2005;53:337–42. https://doi.org/10.1002/art.21179.

    Article  CAS  PubMed  Google Scholar 

  28. Shibuya M, Fujio K, Morita K, Harada H, Kanda H, Yamamoto K. Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis. Mod Rheumatol. 2013;23:577–81. https://doi.org/10.1007/s10165-012-0691-0.

    Article  PubMed  Google Scholar 

  29. Vollersten R. Vasculitis and Cogan’s syndrome. Rheum Dis Clin N Am. 1990;16:433–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriela Mabel Espinoza.

Ethics declarations

Conflict of Interest

The authors declare no conflict of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Autoimmunity

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Espinoza, G.M., Wheeler, J., Temprano, K.K. et al. Cogan’s Syndrome: Clinical Presentations and Update on Treatment. Curr Allergy Asthma Rep 20, 46 (2020). https://doi.org/10.1007/s11882-020-00945-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-020-00945-1

Keywords

Navigation